Also, by evaluating diagnostic value of UBE2C and its correlation with different immune‐related signatures, we conclude that UBE2C is be a theranostic gene, which may serve as a reliable biomarker in diagnosing cancers, improving treatment responses, and increasing the overall survival of cancer patients and can be a promising gene to be target by cancer drugs in the future. Here, UBE2C is linked to cancer.